Your browser doesn't support javascript.
loading
FGFC1 Selectively Inhibits Erlotinib-Resistant Non-Small Cell Lung Cancer via Elevation of ROS Mediated by the EGFR/PI3K/Akt/mTOR Pathway.
Yan, Shike; Zhang, Bing; Feng, Jingwen; Wu, Haigang; Duan, Namin; Zhu, Yamin; Zhao, Yueliang; Shen, Shuang; Zhang, Kai; Wu, Wenhui; Liu, Ning.
Afiliación
  • Yan S; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
  • Zhang B; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
  • Feng J; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
  • Wu H; School of Life Sciences, Henan University, Kaifeng, China.
  • Duan N; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
  • Zhu Y; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
  • Zhao Y; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
  • Shen S; Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Zhang K; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Wu W; Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai, China.
  • Liu N; Engineering Research Center of Aquatic-Product Processing & Preservation, Shanghai, China.
Front Pharmacol ; 12: 764699, 2021.
Article en En | MEDLINE | ID: mdl-35126111

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China